Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02036307 · ClinicalTrials.gov registry record · Phase 2
Supplementation With Omega-3: Mechanism of Action
A Phase 2 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT02036307: Clinical Trial Phase 2 study, sponsored by Johns Hopkins University.
NCT02036307 is a Phase 2 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 13 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02036307, a Phase 2 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
This is a trial of two marketed fish oil supplements, one with a high EPA:DHA ratio and the other with a high DHA:EPA ratio, to examine differential effects on platelet function, blood pressure, and fasting triglyceride levels.
Primary Outcome
Fasting serum triglyceride levels
Interventions
- DIETARY_SUPPLEMENT DHA-enriched
- DIETARY_SUPPLEMENT EPA-enriched
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2013-04 |
| Est. Completion | 2015-01 |
| Phase | Phase 2 |
Why NCT02036307 stopped before completion
NCT02036307 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which DHA-enriched is the first listed.
NCT02036307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02036307 about?
NCT02036307 is a clinical study titled "Supplementation With Omega-3: Mechanism of Action". This is a trial of two marketed fish oil supplements, one with a high EPA:DHA ratio and the other with a high DHA:EPA ratio, to examine differential effects on platelet function, blood pressure, and fasting triglyceride levels.
What is the current status of trial NCT02036307?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2013-04. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02036307?
The interventions under investigation include: DHA-enriched (DIETARY_SUPPLEMENT), EPA-enriched (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02036307?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02036307's enrollment target sits among peer trials
13 1947th of 2000 higher than 53 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia